# OCS-X Founder Post-Trial Authorization

OBJECT = OCSX-FOUNDER-POST-TRIAL-AUTHORIZATION-001
MISSION = REIS-OS-OCSX-PHYSIOLOGICAL-EXPERIMENTAL-LINEAGE-001
AUTHORITY = FOUNDER
DECISION = APPROVED
SOURCE_ASSURANCE = OCSX-FINAL-INDEPENDENT-POST-TRIAL-ASSURANCE-001
SOURCE_ASSURANCE_VERDICT = PASS_WITH_RESERVATIONS
READY_FOR_FOUNDER_POST_TRIAL_DECISION = TRUE

## Authorized consequence

The Founder authorizes entry into the next institutional phase:

OCSX_L1_MATERIALIZATION_AND_QUALIFICATION = AUTHORIZED

Authorized scope:
- materialize an L1 candidate mechanism above the frozen ancestral L0;
- preserve L0 identity and ancestry without mutation;
- qualify L1 mechanism semantics, authority isolation, stop/fencing, evidence, and recovery;
- execute synthetic/non-production qualification tests;
- produce a bounded evidence package for independent assurance.

## Explicitly not authorized

PRODUCTION_ROUTING = FORBIDDEN
CANONICAL_STATE_WRITE = FORBIDDEN
OURO_ACCESS = FORBIDDEN
CROSS_OCS_NAMESPACE_WRITE = FORBIDDEN
KERNEL_AUTHORITY_MUTATION = FORBIDDEN
ADOPTION = FORBIDDEN
PROMOTION = FORBIDDEN
MERGE_PR74 = NOT_AUTHORIZED
UNIVERSAL_DEPLOYMENT = FORBIDDEN
REAL_WORLD_DECISION_AUTHORITY = NOT_GRANTED

L1 MAY MODIFY MECHANISM
L1 MUST NOT MODIFY IDENTITY
CAPABILITY != AUTHORITY
IMPLEMENTATION != EVIDENCE != ASSURANCE != PROMOTION

## Reservations carried forward

- Stage B hashes were MODEL_DERIVED and are not cryptographic runtime proof.
- PT-008 empty-tool preservation is supported by combined Stage A + Stage B evidence.
- Paired cognitive comparison used the same Gemini host/model for two frozen profiles.
- Trial evidence is synthetic and is not real-world production-quality evidence.
- Builder role must remain distinct from final independent assurance.

## Exit ceiling

Maximum consequence of this authorization without a later Founder decision:

READY_FOR_L1_INDEPENDENT_ASSURANCE

It does not authorize production, adoption, promotion, canonical mutation, or merge.